EIOPA · 2189
Solvency Capital Requirement (SCR)
- Regulation
- (EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII)
- Article
- 155
- Topic
- Solvency Capital Requirement (SCR)
- Submitted
- 2020-09-08
- Answered
- 2021-06-28
Question
We kindly ask you for clarification regarding an issue about the capital requirement for medical expense (disability-mordidity risk) according to article 155 of the delegated regulation. Which scenario (increase/decrease of medical payments) should be selected for the gross solvency capital requirement - the one with the higher gross requirement or (if different) the one corresponding to the higher net solvency capital requirement similar to other parts in the SCR calculation where the latter is used?
Background
In a few different articles there is a special mention of article 206, in that out of multiple Scenario possibilities, you have to use the gross value out of the scenario with the highest net value: art. 142 lapse risk, art. 159 SLT health lapse Risk, art. 165 interest rate Risk, art. 179 spread Risk on credit derivatives. However for article 155, there is no such mention. Therefore we are not sure, if in spirit with the rest of the delegated regulation one has to use the highest gross value or the gross value of the scenario with the highest net value.
Answer
The scenario producing the higher net solvency capital requirement is to be used.
This Q&A is published by European Insurance and Occupational Pensions Authority and is non-binding. It does not constitute legal advice. Updated weekly from official ESA sources.
Similar Q&As
More Q&As on this topic
📋 Track EU financial regulation continuously
Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.
14-day free trial. No credit card required.